- Home
- FRBA vs ANGO Comparison
FRBA vs ANGO Comparison
Compare FRBA & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRBA | ANGO |
|---|---|---|
| Founded | 2007 | 1988 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.6M | 427.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FRBA | ANGO |
|---|---|---|
| Price | $17.28 | $11.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $19.00 | ★ $19.33 |
| AVG Volume (30 Days) | 70.7K | ★ 462.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.06 | $9.11 |
| Revenue Next Year | $5.86 | $4.94 |
| P/E Ratio | $9.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.74 | $8.27 |
| 52 Week High | $18.11 | $13.99 |
Technical Indicators
Market Signals| Indicator | FRBA | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 59.77 | 54.33 |
| Support Level | $17.02 | $10.66 |
| Resistance Level | $17.52 | $11.78 |
| Average True Range (ATR) | 0.44 | 0.49 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 85.61 | 72.55 |
Price Performance
Historical ComparisonAbout FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.